US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

登録

ホーム
投資
株式
アメリカ
NYSE
ADC Therapeutics SA (ADCT)
ADC Therapeutics SA (ADCT) ニュース

ADCT

ADC Therapeutics (ADCT)

ADC Therapeutics SA

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:ADCT

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/19	10 : 41	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:ADCT	ADC Therapeutics SA
2024/06/19	10 : 40	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:ADCT	ADC Therapeutics SA
2024/06/19	10 : 38	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:ADCT	ADC Therapeutics SA
2024/06/15	06 : 40	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:ADCT	ADC Therapeutics SA
2024/06/15	06 : 37	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:ADCT	ADC Therapeutics SA
2024/06/15	06 : 23	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:ADCT	ADC Therapeutics SA
2024/06/15	05 : 11	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:ADCT	ADC Therapeutics SA
2024/06/07	04 : 33	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NYSE:ADCT	ADC Therapeutics SA
2024/06/04	05 : 05	GlobeNewswire Inc.	ADC Therapeutics Makes Grants to New Employees Under Inducement Plan	NYSE:ADCT	ADC Therapeutics SA
2024/05/30	20 : 15	GlobeNewswire Inc.	ADC Therapeutics to Participate in the Jefferies Global Healthcare Conference	NYSE:ADCT	ADC Therapeutics SA
2024/05/15	20 : 15	GlobeNewswire Inc.	ADC Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ	NYSE:ADCT	ADC Therapeutics SA
2024/05/15	01 : 32	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:ADCT	ADC Therapeutics SA
2024/05/10	05 : 06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:ADCT	ADC Therapeutics SA
2024/05/09	20 : 15	GlobeNewswire Inc.	ADC Therapeutics to Participate in 2024 RBC Capital Markets Global Healthcare Conference	NYSE:ADCT	ADC Therapeutics SA
2024/05/09	05 : 07	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:ADCT	ADC Therapeutics SA
2024/05/08	05 : 06	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NYSE:ADCT	ADC Therapeutics SA
2024/05/08	05 : 02	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NYSE:ADCT	ADC Therapeutics SA
2024/05/06	20 : 30	GlobeNewswire Inc.	ADC Therapeutics Announces $105 Million Underwritten Offering of Common Shares and Pre-Funded Warrants	NYSE:ADCT	ADC Therapeutics SA
2024/05/06	19 : 51	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NYSE:ADCT	ADC Therapeutics SA
2024/05/06	19 : 38	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NYSE:ADCT	ADC Therapeutics SA
2024/05/06	19 : 29	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:ADCT	ADC Therapeutics SA
2024/05/06	19 : 10	GlobeNewswire Inc.	ADC Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates	NYSE:ADCT	ADC Therapeutics SA
2024/05/06	19 : 00	GlobeNewswire Inc.	ADC Therapeutics Announces Initial Data from Investigator-Initiated Phase 2 Clinical Trial of ZYNLONTA® in Patients with Relapsed/Refractory Marginal Zone Lymphoma	NYSE:ADCT	ADC Therapeutics SA
2024/05/02	05 : 05	GlobeNewswire Inc.	ADC Therapeutics Makes Grants to New Employees Under Inducement Plan	NYSE:ADCT	ADC Therapeutics SA
2024/05/01	20 : 00	GlobeNewswire Inc.	ADC Therapeutics to Host First Quarter 2024 Financial Results and Pipeline Update Conference Call on May 6, 2024	NYSE:ADCT	ADC Therapeutics SA
2024/04/04	20 : 00	GlobeNewswire Inc.	ADC Therapeutics Announces Updates on LOTIS-7 Clinical Trial Evaluating ZYNLONTA® in Combination with Glofitamab or Mosunetuzumab in Patients with Relapsed/Refractory B-cell Non-Hodgkin Lymphoma	NYSE:ADCT	ADC Therapeutics SA
2024/04/03	20 : 00	GlobeNewswire Inc.	ADC Therapeutics to Host a Virtual Research Investor Event on Tuesday, April 9, 2024	NYSE:ADCT	ADC Therapeutics SA
2024/04/02	05 : 05	GlobeNewswire Inc.	ADC Therapeutics Makes Grants to New Employees Under Inducement Plan	NYSE:ADCT	ADC Therapeutics SA
2024/03/13	20 : 03	IH Market News	Mixed Futures Amidst Quiet Economic Schedule; Oil Prices Climb	NYSE:ADCT	ADC Therapeutics SA
2024/03/13	20 : 00	GlobeNewswire Inc.	ADC Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates	NYSE:ADCT	ADC Therapeutics SA

Showing the most relevant articles for your search:NYSE:ADCT

1 2 3 4 5 6 7 8 9 10 次へ >>

John Hancock Lifetime Bl...

Societe Generale Societe...

Jupiter Mines (PK)

Arisawa Manufacturing (PK)

Electricite de France

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約